Eternogen particles
Eternogen 20aesthetics 20logo

EternoGen Aesthetics Equity Round

EternoGen Aestehtics is a clinical stage Medical Device company commercializing a transformative pipeline of liquid collagen products for the Aesthetic market.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Columbia, MO, US
  • Currency USD
  • Founded July 2014
  • Employees 10
  • Incorporation Type LLC
  • Website eternogen.com

Company Summary

EternoGen Aesthetics, LLC is a clinical stage Medical Device company that has developed a transformative pipeline of first-in-class liquid Collagen tissue products to restore lost dermal collagen, naturally reinforcing skin to provide long-term health & radiance. EternoGen is led by a group of proven industry veterans with strong industry connections needed for a successful commercialization into the aesthetic medicine market.
(MTC feature below)

Team

  • Default avatar
    Anna Tenstam
    Chairman and Chief Executive Officer

    Anna has a proven record of success with over 20 years of senior management experience in the medical aesthetic industry. She is recognized as a visionary with her latest success being Evolence, the product that most closely resembles EternoGen's proposition. She played a key role in commercializing Evolence and securing an exit. Mrs. Lundvall has a tremendous rapport with industry-leading physicians and market leading firms.

  • Default avatar
    Luis Jimenez
    President and COO

    Luis's experience includes operations, quality control in cGMP manufacturing, regulatory affairs for manufacturing, design engineering, technology transfer and project management. Mr. Jimenez’s background includes Chemical Engineering, Cum Laude and a Masters of Business Administration with Academic Excellence.

  • Default avatar
    Sheila Grant
    Chief Technology Officer

    Dr. Grant is a founder and expert technological platform manager. She is an expert in synthetic and organic tissue engineering at the University of Missouri. Her specific research interests involve developing nanostructured biocomposites. Her work addresses in-vivo analysis of tissue integration into novel biocomposites for soft tissue replacement as well as materials characterization of explanted biomaterials.

  • Default avatar
    Charles Weatherstone
    Chief Commercialization Officer

    He is a specialist in medical aesthetic marketing, having been responsible for the development, launch and management of a number of market leading brands including JUVEDERM ULTRA, BOTOX, and RESTYLANE. Charles has almost 20 years experience in blue chip and start-up health care marketing covering both medical device and pharmaceutical sectors.

  • Default avatar
    Dale Devore
    Chief Scientific Officer

    Dr. DeVore is a leading commercialization scientific expert in collagen dermal filler products. His experience in dermal fillers includes: founding Autologen, VP of RD for Radiese (in FDA panel meetings), and Sculptra. Dale brings over 35 years in clinical development and R&D. He has authored over 15 patents in dermal filler innovations. He excels in expertise and experience of formulations, troubleshooting issues and solving complex issues.